Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab
Enterovirus encephalitis is a rare but serious complication in pwMS receiving ocrelizumab; hypogammaglobulinemia may increase risk. Clinician awareness and prompt testing may improve outcomes.
Authors
- Eoin P. Flanagan (ORCID: https://orcid.org/0000-0002-6661-2910)
- Nabeela Nathoo (ORCID: https://orcid.org/0000-0001-6446-1146)
- Samantha A. Banks (ORCID: https://orcid.org/0000-0002-5856-1367)
- Michel Toledano
- Ilia Poliakov
Institutions
- University of Alberta (CA)
- University of Saskatchewan (CA)
- Mayo Clinic in Arizona (US)
- Women and Children’s Health Research Institute (CA)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1212/nxi.0000000000200534
- Citations
- 2
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.78